Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed Hashemi Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Alì Mansournia
Abstract
We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).
Topics & Concepts
SeroprevalenceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyCoronavirus InfectionsGeographyBiologyMedicineOutbreakAntibodySerologyInfectious disease (medical specialty)ImmunologyDiseasePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 diagnosis using AI